UTHR
United Therapeutics Corporation · Healthcare
EVP and General Counsel Paul A Mahon sold $4.0M of United Therapeutics Corporation
Sold$4,010,187
$483.16Price
8,300Shares
−18%Stake
What UTHR did after the filing
- The stock from Fri, Mar 6 open, $478.05
- +20.0%
- S&P 500, same days
- +5.2%
Measured over 30 trading days, to the Apr 20 close.
Traded Thu, Mar 5. Filed Thu, Mar 5, 4:37 PM ET, after the close. Returns use the Mar 6 open and the Apr 20 close. Not investment advice.